Clarithromycin-13C, d3

• Description:

  Clarithromycin-13C, d3 is the deuterium and 13C labeled Clarithromycin[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302

• Target:

  Antibiotic; Autophagy; Bacterial; Cytochrome P450; Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Anti-infection; Autophagy; Metabolic Enzyme/Protease; Others

• Field of Research:

  Others

• Purity:

  99.9

• Solubility:

  DMSO : 33.33 mg/mL (ultrasonic; warming)

• Smiles:

  O=C1[C@@H] (C[C@] (C) ([C@@H] ([C@H] ([C@@H] ([C@H] (C (O[C@@H] ([C@] (C) ([C@@H] ([C@H]1C) O) O) CC) =O) C) O[C@]2 (C[C@@] (OC) ([C@H] ([C@@H] (O2) C) O) C) [H]) C) O[C@]3 ([C@@H] ([C@H] (C[C@H] (O3) C) N ([13C] ([2H]) ([2H]) [2H]) C) O) [H]) OC) C

• Molecular Formula:

  C37 13CH66D3NO13

• Molecular Weight:

  751.96

• Precautions:

  H302

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C, 3 years (Powder)

• Scientific Category:

  Isotope-Labeled Compounds

• Clinical Information:

  No Development Reported

• CAS Number:

  2699608-30-3